Tanizawa Y, Kaku K, Araki E et al.
Tofogliflozin 004 and 005 Study Group. Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials.
Expert Opin Pharmacother 2014;
We do not assume any responsibility for the contents of the web pages of other providers.